GHP Investment Advisors, Inc. - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
GHP Investment Advisors, Inc. ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,000
-66.7%
90,0000.0%0.00%
-100.0%
Q2 2022$15,000
-64.3%
90,0000.0%0.00%
-66.7%
Q1 2022$42,000
-17.6%
90,0000.0%0.00%
-25.0%
Q4 2021$51,000
-65.8%
90,0000.0%0.00%
-66.7%
Q3 2021$149,000
-0.7%
90,0000.0%0.01%0.0%
Q2 2021$150,000
-1.3%
90,0000.0%0.01%
-7.7%
Q1 2021$152,000
+6.3%
90,0000.0%0.01%
-7.1%
Q4 2020$143,000
+66.3%
90,0000.0%0.01%
+40.0%
Q3 2020$86,000
+50.9%
90,0000.0%0.01%
+42.9%
Q2 2020$57,000
+35.7%
90,000
-10.0%
0.01%
+16.7%
Q1 2020$42,000
-27.6%
100,0000.0%0.01%0.0%
Q4 2019$58,000
+16.0%
100,0000.0%0.01%0.0%
Q3 2019$50,000
+28.2%
100,0000.0%0.01%
+20.0%
Q2 2019$39,000
-30.4%
100,0000.0%0.01%
-28.6%
Q1 2019$56,000
+43.6%
100,0000.0%0.01%
+16.7%
Q4 2018$39,000
-23.5%
100,0000.0%0.01%
-14.3%
Q3 2018$51,000
-76.8%
100,0000.0%0.01%
-77.4%
Q2 2018$220,000
-35.3%
100,0000.0%0.03%
-35.4%
Q1 2018$340,000
-16.5%
100,0000.0%0.05%
-17.2%
Q4 2017$407,000
+567.2%
100,0000.0%0.06%
+544.4%
Q3 2017$61,000
+17.3%
100,0000.0%0.01%
+12.5%
Q2 2017$52,000
-35.0%
100,0000.0%0.01%
-42.9%
Q1 2017$80,000
-1.2%
100,000
+11.1%
0.01%
-6.7%
Q4 2016$81,000
+20.9%
90,0000.0%0.02%
+7.1%
Q3 2016$67,000
-42.2%
90,0000.0%0.01%
-44.0%
Q2 2016$116,000
-42.9%
90,0000.0%0.02%
-45.7%
Q1 2016$203,000
-11.0%
90,000
+38.5%
0.05%
-16.4%
Q4 2015$228,000
+21.3%
65,0000.0%0.06%
+12.2%
Q3 2015$188,000
+17.5%
65,000
+18.2%
0.05%
+25.6%
Q2 2015$160,000
-64.6%
55,000
-8.3%
0.04%
-66.9%
Q1 2015$452,000
+148.4%
60,000
+13.2%
0.12%
+136.0%
Q4 2014$182,000
+2.8%
53,000
+6.0%
0.05%
-3.8%
Q3 2014$177,000
-57.7%
50,0000.0%0.05%
-57.7%
Q2 2014$418,000
+31.4%
50,0000.0%0.12%
+21.8%
Q1 2014$318,000
-10.9%
50,0000.0%0.10%
-14.4%
Q4 2013$357,000
+19.0%
50,000
+25.0%
0.12%
+8.3%
Q3 2013$300,000
+29.9%
40,0000.0%0.11%
+18.5%
Q2 2013$231,00040,0000.09%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CVA Family Office, LLC 1,173,200$1,865,0001.14%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$1,387,0000.82%
Cypress Capital Management LLC (WY) 214,575$341,0000.30%
Western Wealth Management, LLC 982,350$1,562,0000.23%
SRS Capital Advisors, Inc. 615,659$979,0000.14%
Willis Investment Counsel 1,213,053$1,929,0000.13%
Harvest Investment Services, LLC 124,423$197,0000.10%
Transform Wealth, LLC 205,481$327,0000.07%
COURIER CAPITAL LLC 379,973$604,0000.07%
BRIGHTON JONES LLC 398,912$634,0000.04%
View complete list of AMPIO PHARMACEUTICALS INC shareholders